PolyPeptide Group AG (SWX:PPGN)
Switzerland · Delayed Price · Currency is CHF 24.95
-0.70 (-2.73%)
At close: Dec 19, 2025
PolyPeptide Group AG Market Cap
PolyPeptide Group AG has a market cap or net worth of 823.14 million as of December 19, 2025. Its market cap has decreased by -11.66% in one year.
Market Cap
823.14M
Enterprise Value
855.47M
Revenue
344.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.95
Market Cap Chart
Since April 29, 2021, PolyPeptide Group AG's market cap has decreased from 2.59B to 823.14M, a decrease of -68.22%. That is a compound annual growth rate of -21.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 823.14M | -12.13% |
| Dec 30, 2024 | 936.73M | 62.30% |
| Dec 29, 2023 | 577.18M | -30.79% |
| Dec 30, 2022 | 833.98M | -81.57% |
| Dec 30, 2021 | 4.53B | 74.70% |
| Apr 29, 2021 | 2.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 273.36B |
| Novartis AG | 206.73B |
| Galderma Group AG | 39.12B |
| Lonza Group AG | 37.24B |
| Alcon | 31.28B |
| Sandoz Group AG | 25.02B |
| Straumann Holding AG | 15.06B |
| Sonova Holding AG | 12.31B |